These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15476492)

  • 1. Reduced incidence of new-onset diabetes mellitus after renal transplantation with 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors (statins).
    Prasad GV; Kim SJ; Huang M; Nash MM; Zaltzman JS; Fenton SS; Cattran DC; Cole EH; Cardella CJ
    Am J Transplant; 2004 Nov; 4(11):1897-903. PubMed ID: 15476492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and genetic risk factors for new-onset diabetes mellitus after transplantation (NODAT) in major transplant centres in Malaysia.
    Guad RM; Taylor-Robinson AW; Wu YS; Gan SH; Zaharan NL; Basu RC; Liew CSL; Wan Md Adnan WAH
    BMC Nephrol; 2020 Sep; 21(1):388. PubMed ID: 32894076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survival.
    Younas N; Wu CM; Shapiro R; McCauley J; Johnston J; Tan H; Basu A; Schaefer H; Smetanka C; Winkelmayer WC; Unruh M
    BMC Nephrol; 2010 Apr; 11():5. PubMed ID: 20359353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin Use Is Prospectively Associated With New-Onset Diabetes After Transplantation in Renal Transplant Recipients.
    Szili-Torok T; Bakker SJL; Tietge UJF
    Diabetes Care; 2020 Aug; 43(8):1945-1947. PubMed ID: 32444455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes mellitus after kidney transplantation in Japanese patients: The Japan Academic Consortium of Kidney Transplantation study.
    Okumi M; Unagami K; Hirai T; Shimizu T; Ishida H; Tanabe K;
    Int J Urol; 2017 Mar; 24(3):197-204. PubMed ID: 27862344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of diabetes, angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker use, and statin use on presentation and outcomes in patients with giant cell arteritis.
    Ma J; Khalidi N; Wierzbicki O; Alqutami A; Ioannidis G; Pagnoux C
    Int J Rheum Dis; 2020 Aug; 23(9):1233-1239. PubMed ID: 32776676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of diabetes in patients treated with HMG-CoA reductase inhibitors.
    Cho Y; Choe E; Lee YH; Seo JW; Choi Y; Yun Y; Wang HJ; Ahn CW; Cha BS; Lee HC; Kang ES
    Metabolism; 2015 Apr; 64(4):482-8. PubMed ID: 25312577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin therapy is associated with the development of new-onset diabetes after transplantation in liver recipients with high fasting plasma glucose levels.
    Cho Y; Lee MJ; Choe EY; Jung CH; Joo DJ; Kim MS; Cha BS; Park JY; Kang ES
    Liver Transpl; 2014 May; 20(5):557-63. PubMed ID: 24477986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk and renal transplantation: post hoc analyses of the Assessment of Lescol in Renal Transplantation (ALERT) Study.
    Jardine AG; Fellström B; Logan JO; Cole E; Nyberg G; Grönhagen-Riska C; Madsen S; Neumayer HH; Maes B; Ambühl P; Olsson AG; Pedersen T; Holdaas H
    Am J Kidney Dis; 2005 Sep; 46(3):529-36. PubMed ID: 16129216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective, multicenter, randomized trial to compare incidence of new-onset diabetes mellitus and glucose metabolism in patients receiving cyclosporine microemulsion versus tacrolimus after de novo kidney transplantation.
    Vincenti F; Tuncer M; Castagneto M; Klinger M; Friman S; Scheuermann EH; Wiecek A; Russ GR; Martinek A; Nonnast-Daniel B;
    Transplant Proc; 2005 Mar; 37(2):1001-4. PubMed ID: 15848604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
    Lee J; Lee S
    Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New-onset diabetes after transplantation: drug-related risk factors.
    Santos L; Rodrigo E; Piñera C; Quintella E; Ruiz JC; Fernández-Fresnedo G; Palomar R; Gómez-Alamillo C; de Francisco A; Arias M
    Transplant Proc; 2012 Nov; 44(9):2585-7. PubMed ID: 23146462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin-associated incident diabetes: a literature review.
    Park ZH; Juska A; Dyakov D; Patel RV
    Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin-Angiotensin-Aldosterone system inhibitors and statins prolong graft survival in post-transplant glomerulonephritis.
    Pazik J; Ostrowska J; Lewandowski Z; Mróz A; Perkowska-Ptasińska A; Baczkowska T; Durlik M
    Ann Transplant; 2008; 13(4):41-5. PubMed ID: 19034222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative risk of new-onset diabetes during the first year after renal transplantation in patients receiving tacrolimus or cyclosporine immunosuppression.
    Hoitsma AJ; Hilbrands LB
    Clin Transplant; 2006; 20(5):659-64. PubMed ID: 16968494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of combined therapy with angiotensin-converting enzyme inhibitors and statins in reducing mortality in diabetic patients with critical limb ischemia: an observational study.
    Faglia E; Clerici G; Scatena A; Caminiti M; Curci V; Morabito A; Prisco V; Greco R; Edmonds M
    Diabetes Res Clin Pract; 2014 Feb; 103(2):292-7. PubMed ID: 24492022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins benefit outcomes of renal transplant recipients on a sirolimus-cyclosporine regimen.
    Lisik W; Schoenberg L; Lasky RE; Kahan BD
    Transplant Proc; 2007 Dec; 39(10):3086-92. PubMed ID: 18089328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous glucose monitoring after kidney transplantation in non-diabetic patients: early hyperglycaemia is frequent and may herald post-transplantation diabetes mellitus and graft failure.
    Wojtusciszyn A; Mourad G; Bringer J; Renard E
    Diabetes Metab; 2013 Oct; 39(5):404-10. PubMed ID: 23999231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMG CoA reductase inhibitor treatment induces dysglycemia in renal allograft recipients.
    Choe EY; Wang HJ; Kwon O; Cho Y; Huh KH; Kim MS; Kim YS; Ahn CW; Cha BS; Lee HC; Kang ES
    Transplantation; 2014 Feb; 97(4):419-25. PubMed ID: 24285338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.